Home » Topics » Regulatory

Regulatory
RSS

Famotidine for schizophrenia

Sep. 1, 1997

FDA clears new formulation of Imitrex

Sep. 1, 1997

First approval for irbesartan

Sep. 1, 1997

New indication approved for Asacol

Aug. 28, 1997

Tasmar approved in EU for Parkinson's disease

Aug. 28, 1997

Malignant melanoma indication approved for Intron A in U.K.

Aug. 27, 1997

Actiq scheduled for FDA advisory committee review

Aug. 26, 1997

Living human tissue approved for marketing in Canada

Aug. 22, 1997

Supplemental NDA approved for Cipro

Aug. 22, 1997

Infanrix Hep B approved in all EU countries

Aug. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...